Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Capital/Financing Update 2024

Oct 5, 2024

30528_rns_2024-10-05_37d12924-943a-47b5-860e-73ca51ffcd69.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

October 5, 2024

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ) BSE Limited (S crip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Incorporation of Step down Wholly-owned Subsidiary

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that Dr. Reddy's Laboratories SA, Switzerland, ("DRSA") a whollyowned subsidiary of the Company, has incorporated a new wholly-owned subsidiary in Denmark, named "Dr. Reddy's Denmark ApS" on October 4, 2024. Accordingly, Dr. Reddy's Denmark ApS is a step-down wholly-owned subsidiary of the Company.

The details required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, and SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, with respect to the above incorporation of a step down wholly-owned subsidiary is given in Annexure enclosed herewith.

This is for your information and record.

Thanking you.

Yours faithfully, For Dr. Reddy's Laboratories Limited KUMAR RANDHIR SINGH Digitally signed by KUMAR RANDHIR SINGH Date: 2024.10.05 11:10:08 +05'30'

K Randhir Singh Company Secretary, Compliance Officer & Head-CSR

Annexure

Disclosure under Part A Para A(i) of Schedule III read with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

Sl.No Particulars Description
1 Name of the target entity, details in brief suchas size, turnover etc. Dr.Reddy'sLaboratoriesSA,Switzerland,("DRSA") a wholly-owned subsidiary of theCompany, has incorporated a new wholly-ownedsubsidiary in Denmark, named "Dr. Reddy'sDenmark ApS" on October 4, 2024. Accordingly,Dr. Reddy's Denmark ApS is a step-downwholly-owned subsidiary of the Company.Authorized share capital: DKK 40.000 dividedinto shares of DKK 1 or multiples thereof.
Size/Turnover: Not applicable (yet to commencebusiness operations)
2 Whether the acquisition would fall withinrelated party transaction(s) and whether thepromoter/ promoter group/ group companieshave any interest in the entity being acquired?If yes, nature of interest and details thereofand whether the same is done at "arms-length" Dr. Reddy's Denmark ApS is promoted byDRSA, a Wholly Owned Subsidiary of theCompany and therefore is a related party of theCompany.
3 Industry to which the entity being acquiredbelongs Pharmaceutical
4 Objects and effects of acquisition (includingbut not limited to, disclosure of reasons foracquisition of target entity, if its business isoutside the main line of business of the listedentity) Productionofanypharmaceuticalandbiotechnological products, the acquisition, use,purchase and sale of goods of all kinds and inparticular of intellectual property rights andactivities related hereto. Thebusiness of the Dr.Reddy's Denmark ApS is in line with the mainline of business of the Company.
5 Briefdetailsofanygovernmentalorregulatoryapprovalsrequiredfortheacquisition Not Applicable
6 Indicative time period for completion of theacquisition Not Applicable
7 Natureofconsideration-whethercashconsideration or share swap and details of thesame Subscription of shares by DRSA by way of cashconsideration.
8 Cost of acquisition or the price at which theshares are acquired DRSA will be paying cash consideration to theDr. Reddy's Denmark ApS towards subscriptionof100%shareholding.
9 Percentage of shareholding / control acquiredand / or number of shares acquired 100%

10 Brief background about the entity acquired in Purpose: Production of any pharmaceutical and
terms of products/line of business acquired, biotechnological products, the acquisition, use,
date of incorporation, history of last 3 years purchase and sale of goods of all kinds and in
turnover, country in which the acquired entity particular of intellectual property rights and
haspresenceandanyothersignificant activities related hereto.
information (in brief)
Date of Incorporation: October 4, 2024
History/Turnover – Not applicable
Dr. Reddy's Denmark ApS is incorporated in
Denmark and is yet to commence its business
operations.
Country of incorporation: Denmark
KUMAR Digitally signed byKUMAR RANDHIR SINGH
RANDHIR SINGH Date: 2024.10.05 $11:10:48 + 05'30'$